img

Global Real-Time PCR Assays Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Real-Time PCR Assays Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Real-Time PCR Assays market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Real-Time PCR Assays is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The China market for Real-Time PCR Assays is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034.
The Europe market for Real-Time PCR Assays is estimated to increase from $ million in 2023 to reach $ million by 2034, at a CAGR of % during the forecast period of 2023 through 2034..
The global key manufacturers of Real-Time PCR Assays include Roche, BLIRT, Qiagen, Merck, Ampliqon, Applied Biosystems, Bio-Rad, Takara Bio and Illumina, etc. In 2024, the global top five players hold a share approximately % in sales volume, and in term of revenue of Real-Time PCR Assays, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Real-Time PCR Assays by regions (Countries), company, by type and by type. from 2018 to 2023 and forecast to 2034.
The global Real-Time PCR Assays market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Real-Time PCR Assays market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Roche
BLIRT
Qiagen
Merck
Ampliqon
Applied Biosystems
Bio-Rad
Takara Bio
Illumina
Thermo Fisher Scientific
Promega
New England Biolabs
Bioneer
By Type
Relative Quantification
Absolute Quantification
By Application
PCR
RT-PCR
Sales by Region
North America
United States
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Real-Time PCR Assays in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Real-Time PCR Assays manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Real-Time PCR Assays sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Real-Time PCR Assays Definition
1.2 Market by Type
1.2.1 Global Real-Time PCR Assays Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Relative Quantification
1.2.3 Absolute Quantification
1.3 Market Segment by Application
1.3.1 Global Real-Time PCR Assays Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 PCR
1.3.3 RT-PCR
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Real-Time PCR Assays Sales
2.1 Global Real-Time PCR Assays Revenue Estimates and Forecasts 2018-2034
2.2 Global Real-Time PCR Assays Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Real-Time PCR Assays Revenue by Region
2.3.1 Global Real-Time PCR Assays Revenue by Region (2018-2023)
2.3.2 Global Real-Time PCR Assays Revenue by Region (2024-2034)
2.4 Global Real-Time PCR Assays Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Real-Time PCR Assays Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Real-Time PCR Assays Sales Quantity by Region
2.6.1 Global Real-Time PCR Assays Sales Quantity by Region (2018-2023)
2.6.2 Global Real-Time PCR Assays Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Real-Time PCR Assays Sales Quantity by Manufacturers
3.1.1 Global Real-Time PCR Assays Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Real-Time PCR Assays Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Real-Time PCR Assays Sales in 2024
3.2 Global Real-Time PCR Assays Revenue by Manufacturers
3.2.1 Global Real-Time PCR Assays Revenue by Manufacturers (2018-2023)
3.2.2 Global Real-Time PCR Assays Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Real-Time PCR Assays Revenue in 2024
3.3 Global Real-Time PCR Assays Sales Price by Manufacturers
3.4 Global Key Players of Real-Time PCR Assays, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Real-Time PCR Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Real-Time PCR Assays, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Real-Time PCR Assays, Product Offered and Application
3.8 Global Key Manufacturers of Real-Time PCR Assays, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Real-Time PCR Assays Sales Quantity by Type
4.1.1 Global Real-Time PCR Assays Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Real-Time PCR Assays Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
4.2 Global Real-Time PCR Assays Revenue by Type
4.2.1 Global Real-Time PCR Assays Historical Revenue by Type (2018-2023)
4.2.2 Global Real-Time PCR Assays Forecasted Revenue by Type (2024-2034)
4.2.3 Global Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
4.3 Global Real-Time PCR Assays Price by Type
4.3.1 Global Real-Time PCR Assays Price by Type (2018-2023)
4.3.2 Global Real-Time PCR Assays Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Real-Time PCR Assays Sales Quantity by Application
5.1.1 Global Real-Time PCR Assays Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Real-Time PCR Assays Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
5.2 Global Real-Time PCR Assays Revenue by Application
5.2.1 Global Real-Time PCR Assays Historical Revenue by Application (2018-2023)
5.2.2 Global Real-Time PCR Assays Forecasted Revenue by Application (2024-2034)
5.2.3 Global Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
5.3 Global Real-Time PCR Assays Price by Application
5.3.1 Global Real-Time PCR Assays Price by Application (2018-2023)
5.3.2 Global Real-Time PCR Assays Price Forecast by Application (2024-2034)
6 North America
6.1 North America Real-Time PCR Assays Sales by Company
6.1.1 North America Real-Time PCR Assays Revenue by Company (2018-2023)
6.1.2 North America Real-Time PCR Assays Sales Quantity by Company (2018-2023)
6.2 North America Real-Time PCR Assays Market Size by Type
6.2.1 North America Real-Time PCR Assays Sales Quantity by Type (2018-2034)
6.2.2 North America Real-Time PCR Assays Revenue by Type (2018-2034)
6.3 North America Real-Time PCR Assays Market Size by Application
6.3.1 North America Real-Time PCR Assays Sales Quantity by Application (2018-2034)
6.3.2 North America Real-Time PCR Assays Revenue by Application (2018-2034)
6.4 North America Real-Time PCR Assays Market Size by Country
6.4.1 North America Real-Time PCR Assays Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Real-Time PCR Assays Revenue by Country (2018-2034)
6.4.3 North America Real-Time PCR Assays Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Real-Time PCR Assays Sales by Company
7.1.1 Europe Real-Time PCR Assays Sales Quantity by Company (2018-2023)
7.1.2 Europe Real-Time PCR Assays Revenue by Company (2018-2023)
7.2 Europe Real-Time PCR Assays Market Size by Type
7.2.1 Europe Real-Time PCR Assays Sales Quantity by Type (2018-2034)
7.2.2 Europe Real-Time PCR Assays Revenue by Type (2018-2034)
7.3 Europe Real-Time PCR Assays Market Size by Application
7.3.1 Europe Real-Time PCR Assays Sales Quantity by Application (2018-2034)
7.3.2 Europe Real-Time PCR Assays Revenue by Application (2018-2034)
7.4 Europe Real-Time PCR Assays Market Size by Country
7.4.1 Europe Real-Time PCR Assays Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Real-Time PCR Assays Revenue by Country (2018-2034)
7.4.3 Europe Real-Time PCR Assays Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Real-Time PCR Assays Sales by Company
8.1.1 China Real-Time PCR Assays Sales Quantity by Company (2018-2023)
8.1.2 China Real-Time PCR Assays Revenue by Company (2018-2023)
8.2 China Real-Time PCR Assays Market Size by Type
8.2.1 China Real-Time PCR Assays Sales Quantity by Type (2018-2034)
8.2.2 China Real-Time PCR Assays Revenue by Type (2018-2034)
8.3 China Real-Time PCR Assays Market Size by Application
8.3.1 China Real-Time PCR Assays Sales Quantity by Application (2018-2034)
8.3.2 China Real-Time PCR Assays Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Real-Time PCR Assays Sales by Company
9.1.1 APAC Real-Time PCR Assays Sales Quantity by Company (2018-2023)
9.1.2 APAC Real-Time PCR Assays Revenue by Company (2018-2023)
9.2 APAC Real-Time PCR Assays Market Size by Type
9.2.1 APAC Real-Time PCR Assays Sales Quantity by Type (2018-2034)
9.2.2 APAC Real-Time PCR Assays Revenue by Type (2018-2034)
9.3 APAC Real-Time PCR Assays Market Size by Application
9.3.1 APAC Real-Time PCR Assays Sales Quantity by Application (2018-2034)
9.3.2 APAC Real-Time PCR Assays Revenue by Application (2018-2034)
9.4 APAC Real-Time PCR Assays Market Size by Region
9.4.1 APAC Real-Time PCR Assays Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Real-Time PCR Assays Revenue by Region (2018-2034)
9.4.3 APAC Real-Time PCR Assays Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Real-Time PCR Assays Sales by Company
10.1.1 Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Real-Time PCR Assays Market Size by Type
10.2.1 Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Real-Time PCR Assays Market Size by Application
10.3.1 Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Real-Time PCR Assays Market Size by Country
10.4.1 Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Roche Real-Time PCR Assays Products and Services
11.1.5 Roche Real-Time PCR Assays SWOT Analysis
11.1.6 Roche Recent Developments
11.2 BLIRT
11.2.1 BLIRT Company Information
11.2.2 BLIRT Overview
11.2.3 BLIRT Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 BLIRT Real-Time PCR Assays Products and Services
11.2.5 BLIRT Real-Time PCR Assays SWOT Analysis
11.2.6 BLIRT Recent Developments
11.3 Qiagen
11.3.1 Qiagen Company Information
11.3.2 Qiagen Overview
11.3.3 Qiagen Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Qiagen Real-Time PCR Assays Products and Services
11.3.5 Qiagen Real-Time PCR Assays SWOT Analysis
11.3.6 Qiagen Recent Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Overview
11.4.3 Merck Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Merck Real-Time PCR Assays Products and Services
11.4.5 Merck Real-Time PCR Assays SWOT Analysis
11.4.6 Merck Recent Developments
11.5 Ampliqon
11.5.1 Ampliqon Company Information
11.5.2 Ampliqon Overview
11.5.3 Ampliqon Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Ampliqon Real-Time PCR Assays Products and Services
11.5.5 Ampliqon Real-Time PCR Assays SWOT Analysis
11.5.6 Ampliqon Recent Developments
11.6 Applied Biosystems
11.6.1 Applied Biosystems Company Information
11.6.2 Applied Biosystems Overview
11.6.3 Applied Biosystems Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Applied Biosystems Real-Time PCR Assays Products and Services
11.6.5 Applied Biosystems Real-Time PCR Assays SWOT Analysis
11.6.6 Applied Biosystems Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Information
11.7.2 Bio-Rad Overview
11.7.3 Bio-Rad Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 Bio-Rad Real-Time PCR Assays Products and Services
11.7.5 Bio-Rad Real-Time PCR Assays SWOT Analysis
11.7.6 Bio-Rad Recent Developments
11.8 Takara Bio
11.8.1 Takara Bio Company Information
11.8.2 Takara Bio Overview
11.8.3 Takara Bio Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 Takara Bio Real-Time PCR Assays Products and Services
11.8.5 Takara Bio Real-Time PCR Assays SWOT Analysis
11.8.6 Takara Bio Recent Developments
11.9 Illumina
11.9.1 Illumina Company Information
11.9.2 Illumina Overview
11.9.3 Illumina Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Illumina Real-Time PCR Assays Products and Services
11.9.5 Illumina Real-Time PCR Assays SWOT Analysis
11.9.6 Illumina Recent Developments
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Information
11.10.2 Thermo Fisher Scientific Overview
11.10.3 Thermo Fisher Scientific Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Thermo Fisher Scientific Real-Time PCR Assays Products and Services
11.10.5 Thermo Fisher Scientific Real-Time PCR Assays SWOT Analysis
11.10.6 Thermo Fisher Scientific Recent Developments
11.11 Promega
11.11.1 Promega Company Information
11.11.2 Promega Overview
11.11.3 Promega Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Promega Real-Time PCR Assays Products and Services
11.11.5 Promega Recent Developments
11.12 New England Biolabs
11.12.1 New England Biolabs Company Information
11.12.2 New England Biolabs Overview
11.12.3 New England Biolabs Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.12.4 New England Biolabs Real-Time PCR Assays Products and Services
11.12.5 New England Biolabs Recent Developments
11.13 Bioneer
11.13.1 Bioneer Company Information
11.13.2 Bioneer Overview
11.13.3 Bioneer Real-Time PCR Assays Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.13.4 Bioneer Real-Time PCR Assays Products and Services
11.13.5 Bioneer Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Real-Time PCR Assays Value Chain Analysis
12.2 Real-Time PCR Assays Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Real-Time PCR Assays Production Mode & Process
12.4 Real-Time PCR Assays Sales and Marketing
12.4.1 Real-Time PCR Assays Sales Channels
12.4.2 Real-Time PCR Assays Distributors
12.5 Real-Time PCR Assays Customers
13 Market Dynamics
13.1 Real-Time PCR Assays Industry Trends
13.2 Real-Time PCR Assays Market Drivers
13.3 Real-Time PCR Assays Market Challenges
13.4 Real-Time PCR Assays Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Real-Time PCR Assays Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Relative Quantification
Table 3. Major Manufacturers of Absolute Quantification
Table 4. Global Real-Time PCR Assays Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Real-Time PCR Assays Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Real-Time PCR Assays Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Real-Time PCR Assays Revenue Market Share by Region (2018-2023)
Table 8. Global Real-Time PCR Assays Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Real-Time PCR Assays Revenue Market Share by Region (2024-2034)
Table 10. Global Real-Time PCR Assays Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Units)
Table 11. Global Real-Time PCR Assays Sales by Region (2018-2023) & (K Units)
Table 12. Global Real-Time PCR Assays Sales Market Share by Region (2018-2023)
Table 13. Global Real-Time PCR Assays Sales by Region (2024-2034) & (K Units)
Table 14. Global Real-Time PCR Assays Sales Market Share by Region (2024-2034)
Table 15. Global Real-Time PCR Assays Sales Quantity by Manufacturers (2018-2023) & (K Units)
Table 16. Global Real-Time PCR Assays Sales Quantity Share by Manufacturers (2018-2023)
Table 17. Global Real-Time PCR Assays Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Real-Time PCR Assays Revenue Share by Manufacturers (2018-2023)
Table 19. Global Real-Time PCR Assays Price by Manufacturers 2018-2023 (US$/Unit)
Table 20. Global Key Players of Real-Time PCR Assays, Industry Ranking, 2021 VS 2024
Table 21. Global Real-Time PCR Assays Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Real-Time PCR Assays by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Real-Time PCR Assays as of 2024)
Table 23. Global Key Manufacturers of Real-Time PCR Assays, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Real-Time PCR Assays, Product Offered and Application
Table 25. Global Key Manufacturers of Real-Time PCR Assays, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Real-Time PCR Assays Sales Quantity by Type (2018-2023) & (K Units)
Table 28. Global Real-Time PCR Assays Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Real-Time PCR Assays Sales Quantity Share by Type (2018-2023)
Table 30. Global Real-Time PCR Assays Sales Quantity Share by Type (2024-2034)
Table 31. Global Real-Time PCR Assays Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Real-Time PCR Assays Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Real-Time PCR Assays Revenue Share by Type (2018-2023)
Table 34. Global Real-Time PCR Assays Revenue Share by Type (2024-2034)
Table 35. Real-Time PCR Assays Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Real-Time PCR Assays Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Real-Time PCR Assays Sales Quantity by Application (2018-2023) & (K Units)
Table 38. Global Real-Time PCR Assays Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Real-Time PCR Assays Sales Quantity Share by Application (2018-2023)
Table 40. Global Real-Time PCR Assays Sales Quantity Share by Application (2024-2034)
Table 41. Global Real-Time PCR Assays Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Real-Time PCR Assays Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Real-Time PCR Assays Revenue Share by Application (2018-2023)
Table 44. Global Real-Time PCR Assays Revenue Share by Application (2024-2034)
Table 45. Real-Time PCR Assays Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Real-Time PCR Assays Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. North America Real-Time PCR Assays Revenue by Company (2018-2023) & (US$ Million)
Table 48. North America Real-Time PCR Assays Sales Quantity by Company (2018-2023) & (K Units)
Table 49. North America Real-Time PCR Assays Sales Quantity by Type (2018-2023) & (K Units)
Table 50. North America Real-Time PCR Assays Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Real-Time PCR Assays Revenue by Type (2018-2023) & (US$ Million)
Table 52. North America Real-Time PCR Assays Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Real-Time PCR Assays Sales Quantity by Application (2018-2023) & (K Units)
Table 54. North America Real-Time PCR Assays Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Real-Time PCR Assays Revenue by Application (2018-2023) & (US$ Million)
Table 56. North America Real-Time PCR Assays Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Real-Time PCR Assays Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 58. North America Real-Time PCR Assays Revenue by Country (2018-2023) & (US$ Million)
Table 59. North America Real-Time PCR Assays Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Real-Time PCR Assays Sales Quantity by Country (2018-2023) & (K Units)
Table 61. North America Real-Time PCR Assays Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Real-Time PCR Assays Sales Quantity by Company (2018-2023) & (K Units)
Table 63. Europe Real-Time PCR Assays Revenue by Company (2018-2023) & (US$ Million)
Table 64. Europe Real-Time PCR Assays Sales Quantity by Type (2018-2023) & (K Units)
Table 65. Europe Real-Time PCR Assays Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Real-Time PCR Assays Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Real-Time PCR Assays Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Real-Time PCR Assays Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Europe Real-Time PCR Assays Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Real-Time PCR Assays Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Real-Time PCR Assays Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Real-Time PCR Assays Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 73. Europe Real-Time PCR Assays Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Real-Time PCR Assays Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Real-Time PCR Assays Sales Quantity by Country (2018-2023) & (K Units)
Table 76. Europe Real-Time PCR Assays Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Real-Time PCR Assays Sales Quantity by Company (2018-2023) & (K Units)
Table 78. China Real-Time PCR Assays Revenue by Company (2018-2023) & (US$ Million)
Table 79. China Real-Time PCR Assays Sales Quantity by Type (2018-2023) & (K Units)
Table 80. China Real-Time PCR Assays Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Real-Time PCR Assays Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Real-Time PCR Assays Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Real-Time PCR Assays Sales Quantity by Application (2018-2023) & (K Units)
Table 84. China Real-Time PCR Assays Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Real-Time PCR Assays Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Real-Time PCR Assays Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Real-Time PCR Assays Sales Quantity by Company (2018-2023) & (K Units)
Table 88. APAC Real-Time PCR Assays Revenue by Company (2018-2023) & (US$ Million)
Table 89. APAC Real-Time PCR Assays Sales Quantity by Type (2018-2023) & (K Units)
Table 90. APAC Real-Time PCR Assays Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Real-Time PCR Assays Revenue by Type (2018-2023) & (US$ Million)
Table 92. APAC Real-Time PCR Assays Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Real-Time PCR Assays Sales Quantity by Application (2018-2023) & (K Units)
Table 94. APAC Real-Time PCR Assays Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Real-Time PCR Assays Revenue by Application (2018-2023) & (US$ Million)
Table 96. APAC Real-Time PCR Assays Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Real-Time PCR Assays Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 98. APAC Real-Time PCR Assays Revenue by Region (2018-2023) & (US$ Million)
Table 99. APAC Real-Time PCR Assays Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Real-Time PCR Assays Sales Quantity by Region (2018-2023) & (K Units)
Table 101. APAC Real-Time PCR Assays Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Company (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Company (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Type (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Type (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Application (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Real-Time PCR Assays Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Country (2018-2023) & (K Units)
Table 116. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Roche Company Information
Table 118. Roche Description and Overview
Table 119. Roche Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 120. Roche Real-Time PCR Assays Product and Services
Table 121. Roche Real-Time PCR Assays SWOT Analysis
Table 122. Roche Recent Developments
Table 123. BLIRT Company Information
Table 124. BLIRT Description and Overview
Table 125. BLIRT Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 126. BLIRT Real-Time PCR Assays Product and Services
Table 127. BLIRT Real-Time PCR Assays SWOT Analysis
Table 128. BLIRT Recent Developments
Table 129. Qiagen Company Information
Table 130. Qiagen Description and Overview
Table 131. Qiagen Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 132. Qiagen Real-Time PCR Assays Product and Services
Table 133. Qiagen Real-Time PCR Assays SWOT Analysis
Table 134. Qiagen Recent Developments
Table 135. Merck Company Information
Table 136. Merck Description and Overview
Table 137. Merck Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 138. Merck Real-Time PCR Assays Product and Services
Table 139. Merck Real-Time PCR Assays SWOT Analysis
Table 140. Merck Recent Developments
Table 141. Ampliqon Company Information
Table 142. Ampliqon Description and Overview
Table 143. Ampliqon Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 144. Ampliqon Real-Time PCR Assays Product and Services
Table 145. Ampliqon Real-Time PCR Assays SWOT Analysis
Table 146. Ampliqon Recent Developments
Table 147. Applied Biosystems Company Information
Table 148. Applied Biosystems Description and Overview
Table 149. Applied Biosystems Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 150. Applied Biosystems Real-Time PCR Assays Product and Services
Table 151. Applied Biosystems Real-Time PCR Assays SWOT Analysis
Table 152. Applied Biosystems Recent Developments
Table 153. Bio-Rad Company Information
Table 154. Bio-Rad Description and Overview
Table 155. Bio-Rad Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 156. Bio-Rad Real-Time PCR Assays Product and Services
Table 157. Bio-Rad Real-Time PCR Assays SWOT Analysis
Table 158. Bio-Rad Recent Developments
Table 159. Takara Bio Company Information
Table 160. Takara Bio Description and Overview
Table 161. Takara Bio Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 162. Takara Bio Real-Time PCR Assays Product and Services
Table 163. Takara Bio Real-Time PCR Assays SWOT Analysis
Table 164. Takara Bio Recent Developments
Table 165. Illumina Company Information
Table 166. Illumina Description and Overview
Table 167. Illumina Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 168. Illumina Real-Time PCR Assays Product and Services
Table 169. Illumina Real-Time PCR Assays SWOT Analysis
Table 170. Illumina Recent Developments
Table 171. Thermo Fisher Scientific Company Information
Table 172. Thermo Fisher Scientific Description and Overview
Table 173. Thermo Fisher Scientific Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 174. Thermo Fisher Scientific Real-Time PCR Assays Product and Services
Table 175. Thermo Fisher Scientific Real-Time PCR Assays SWOT Analysis
Table 176. Thermo Fisher Scientific Recent Developments
Table 177. Promega Company Information
Table 178. Promega Description and Overview
Table 179. Promega Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 180. Promega Real-Time PCR Assays Product and Services
Table 181. Promega Recent Developments
Table 182. New England Biolabs Company Information
Table 183. New England Biolabs Description and Overview
Table 184. New England Biolabs Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 185. New England Biolabs Real-Time PCR Assays Product and Services
Table 186. New England Biolabs Recent Developments
Table 187. Bioneer Company Information
Table 188. Bioneer Description and Overview
Table 189. Bioneer Real-Time PCR Assays Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2023)
Table 190. Bioneer Real-Time PCR Assays Product and Services
Table 191. Bioneer Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. Real-Time PCR Assays Distributors List
Table 195. Real-Time PCR Assays Customers List
Table 196. Real-Time PCR Assays Market Trends
Table 197. Real-Time PCR Assays Market Drivers
Table 198. Real-Time PCR Assays Market Challenges
Table 199. Real-Time PCR Assays Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Real-Time PCR Assays Product Picture
Figure 2. Global Real-Time PCR Assays Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Real-Time PCR Assays Market Share by Type in 2024 & 2034
Figure 4. Relative Quantification Product Picture
Figure 5. Absolute Quantification Product Picture
Figure 6. Global Real-Time PCR Assays Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Real-Time PCR Assays Market Share by Application in 2024 & 2034
Figure 8. PCR
Figure 9. RT-PCR
Figure 10. Real-Time PCR Assays Report Years Considered
Figure 11. Global Real-Time PCR Assays Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Real-Time PCR Assays Revenue 2018-2034 (US$ Million)
Figure 13. Global Real-Time PCR Assays Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 14. Global Real-Time PCR Assays Sales Quantity 2018-2034 (K Units)
Figure 15. Global Real-Time PCR Assays Sales Quantity Market Share by Region (2018-2023)
Figure 16. Global Real-Time PCR Assays Sales Quantity Market Share by Region (2024-2034)
Figure 17. North America Real-Time PCR Assays Sales Quantity YoY (2018-2034) & (K Units)
Figure 18. North America Real-Time PCR Assays Revenue YoY (2018-2034) & (US$ Million)
Figure 19. Europe Real-Time PCR Assays Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. Europe Real-Time PCR Assays Revenue YoY (2018-2034) & (US$ Million)
Figure 21. China Real-Time PCR Assays Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. China Real-Time PCR Assays Revenue YoY (2018-2034) & (US$ Million)
Figure 23. APAC Real-Time PCR Assays Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. APAC Real-Time PCR Assays Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. Middle East, Africa and Latin America Real-Time PCR Assays Revenue YoY (2018-2034) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Real-Time PCR Assays Sales Quantity in 2024
Figure 28. The Top 10 and Top 5 Players Market Share by Real-Time PCR Assays Revenue in 2024
Figure 29. Real-Time PCR Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 30. Global Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
Figure 31. Global Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
Figure 32. Global Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
Figure 33. Global Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
Figure 34. North America Real-Time PCR Assays Revenue Market Share by Company in 2024
Figure 35. North America Real-Time PCR Assays Sales Quantity Market Share by Company in 2024
Figure 36. North America Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
Figure 37. North America Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
Figure 38. North America Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
Figure 39. North America Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
Figure 40. North America Real-Time PCR Assays Revenue Share by Country (2018-2034)
Figure 41. North America Real-Time PCR Assays Sales Quantity Share by Country (2018-2034)
Figure 42. United States Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Real-Time PCR Assays Sales Quantity Market Share by Company in 2024
Figure 45. Europe Real-Time PCR Assays Revenue Market Share by Company in 2024
Figure 46. Europe Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
Figure 47. Europe Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
Figure 48. Europe Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
Figure 49. Europe Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
Figure 50. Europe Real-Time PCR Assays Revenue Share by Country (2018-2034)
Figure 51. Europe Real-Time PCR Assays Sales Quantity Share by Country (2018-2034)
Figure 52. Germany Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 53. France Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 54. U.K. Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 55. Italy Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 56. Russia Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 57. China Real-Time PCR Assays Sales Quantity Market Share by Company in 2024
Figure 58. China Real-Time PCR Assays Revenue Market Share by Company in 2024
Figure 59. China Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
Figure 60. China Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
Figure 61. China Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
Figure 62. China Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
Figure 63. APAC Real-Time PCR Assays Sales Quantity Market Share by Company in 2024
Figure 64. APAC Real-Time PCR Assays Revenue Market Share by Company in 2024
Figure 65. APAC Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
Figure 66. APAC Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
Figure 67. APAC Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
Figure 68. APAC Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
Figure 69. APAC Real-Time PCR Assays Revenue Share by Region (2018-2034)
Figure 70. APAC Real-Time PCR Assays Sales Quantity Share by Region (2018-2034)
Figure 71. Japan Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 72. South Korea Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 73. China Taiwan Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 75. India Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity Market Share by Company in 2024
Figure 77. Middle East, Africa and Latin America Real-Time PCR Assays Revenue Market Share by Company in 2024
Figure 78. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity Market Share by Type (2018-2034)
Figure 79. Middle East, Africa and Latin America Real-Time PCR Assays Revenue Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity Market Share by Application (2018-2034)
Figure 81. Middle East, Africa and Latin America Real-Time PCR Assays Revenue Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Real-Time PCR Assays Sales Quantity Share by Country (2018-2034)
Figure 83. Middle East, Africa and Latin America Real-Time PCR Assays Revenue Share by Country (2018-2034)
Figure 84. Brazil Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 85. Mexico Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 86. Turkey Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 87. Israel Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 88. GCC Countries Real-Time PCR Assays Revenue (2018-2034) & (US$ Million)
Figure 89. Real-Time PCR Assays Value Chain
Figure 90. Real-Time PCR Assays Production Process
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed